The mGlu2/3 receptor agonist LY379268 injected into cortex or thalamus decreases neuronal injury in retrosplenial cortex produced by NMDA receptor antagonist MK-801: possible implications for psychosis

[1]  K. Hashimoto,et al.  Protective effect of LY379268, a selective group II metabotropic glutamate receptor agonist, on dizocilpine-induced neuropathological changes in rat retrosplenial cortex , 2003, Brain Research.

[2]  C. Swanson,et al.  The Group II Metabotropic Glutamate Receptor Agonist (−)-2-Oxa-4-aminobicyclo[3.1.0.]hexane-4,6-dicarboxylate (LY379268) and Clozapine Reverse Phencyclidine-Induced Behaviors in Monoamine-Depleted Rats , 2002, Journal of Pharmacology and Experimental Therapeutics.

[3]  D. Schoepp.  Metabotropic glutamate receptors , 2002, Pharmacology Biochemistry and Behavior.

[4]  D. Schoepp,et al.  Effects of the mGlu2/3 receptor agonist LY379268 on motor activity in phencyclidine-sensitized rats , 2002, Pharmacology Biochemistry and Behavior.

[5]  W. A. Wilson,et al.  NMDA Receptor Antagonists Disinhibit Rat Posterior Cingulate and Retrosplenial Cortices: A Potential Mechanism of Neurotoxicity , 2002, The Journal of Neuroscience.

[6]  P. Shinnick‐Gallagher,et al.  Long-term behavioral and neurodegenerative effects of perinatal phencyclidine administration: implications for schizophrenia , 2001, Neuroscience.

[7]  D. Schoepp.  Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system. , 2001, The Journal of pharmacology and experimental therapeutics.

[8]  R. Shigemoto,et al.  Distribution of metabotropic glutamate receptor mGluR3 in the mouse CNS: differential location relative to pre- and postsynaptic sites , 2001, Neuroscience.

[9]  Myriam Bernaudin,et al.  Psychosis: pathological activation of limbic thalamocortical circuits by psychomimetics and schizophrenia? , 2001, Trends in Neurosciences.

[10]  S. Nakanishi,et al.  Synthesis, SARs, and pharmacological characterization of 2-amino-3 or 6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives as potent, selective, and orally active group II metabotropic glutamate receptor agonists. , 2000, Journal of medicinal chemistry.

[11]  D. Schoepp,et al.  Regulation of Neurotransmitter Release by Metabotropic Glutamate Receptors , 2000, Journal of neurochemistry.

[12]  F. Sharp,et al.  Fluoxetine prevents PCP- and MK801-induced HSP70 expression in injured limbic cortical neurons of rats , 2000, Biological Psychiatry.

[13]  F. Sharp,et al.  Bilateral blockade of NMDA receptors in anterior thalamus by dizocilpine (MK‐801) injures pyramidal neurons in rat retrosplenial cortex , 2000, The European journal of neuroscience.

[14]  D. Schoepp,et al.  Attenuation of specific PCP-evoked behaviors by the potent mGlu2/3 receptor agonist, LY379268 and comparison with the atypical antipsychotic, clozapine , 2000, Psychopharmacology.

[15]  J. Coyle,et al.  D-serine added to clozapine for the treatment of schizophrenia. , 1999, The American journal of psychiatry.

[16]  D. Jane,et al.  Pharmacological agents acting at subtypes of metabotropic glutamate receptors , 1999, Neuropharmacology.

[17]  D. Schoepp,et al.  The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats. , 1999, The Journal of pharmacology and experimental therapeutics.

[18]  D. Cyril D’Souza,et al.  Interactive effects of subanesthetic ketamine and haloperidol in healthy humans , 1999, Psychopharmacology.

[19]  R. Anwyl.  Metabotropic glutamate receptors: electrophysiological properties and role in plasticity , 1999, Brain Research Reviews.

[20]  F. Sharp,et al.  Acute phencyclidine neurotoxicity in rat forebrain: induction of haem oxygenase‐1 and attenuation by the antioxidant dimethylthiourea , 1998, The European journal of neuroscience.

[21]  B. Moghaddam,et al.  Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. , 1998, Science.

[22]  G. A. Kevetter,et al.  Chronic phencyclidine induces behavioral sensitization and apoptotic cell death in the olfactory and piriform cortex , 1998, Journal of neuroscience research.

[23]  D. Schoepp,et al.  In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats , 1997, Neuroscience Letters.

[24]  A. Boulton,et al.  MK‐801 induces apoptotic neuronal death in the rat retrosplenial cortex: Prevention by cycloheximide and R(−)‐2‐Hexyl‐N‐ Methylpropargylamine , 1996, Journal of Neuroscience Research.

[25]  J. Olney,et al.  Olanzapine and fluperlapine mimic clozapine in preventing MK-801 neurotoxicity , 1996, Schizophrenia Research.

[26]  D. Schoepp,et al.  Synthesis of the four isomers of 4-aminopyrrolidine-2,4-dicarboxylate: identification of a potent, highly selective, and systemically-active agonist for metabotropic glutamate receptors negatively coupled to adenylate cyclase. , 1996, Journal of medicinal chemistry.

[27]  R. Auer,et al.  Effect of age and sex on N-methyl-D-aspartate antagonist-induced neuronal necrosis in rats. , 1996, Stroke.

[28]  J. Olney,et al.  Acute behavioral effects of MK-801 in the mouse , 1996, Pharmacology Biochemistry and Behavior.

[29]  F. Sharp,et al.  Haloperidol Prevents Ketamine- and Phencyclidine-Induced HSP70 Protein Expression but Not Microglial Activation , 1996, Experimental Neurology.

[30]  J. Olney,et al.  Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: Potential relevance to schizophrenia? , 1995, Biological Psychiatry.

[31]  J. Olney,et al.  NMDA Antagonists as Neurotherapeutic Drugs, Psychotogens, Neurotoxins, and Research Tools for Studying Schizophrenia , 1995, Neuropsychopharmacology.

[32]  T. van Groen,et al.  Projections from the anterodorsal and anteroveniral nucleus of the thalamus to the limbic cortex in the rat , 1995, The Journal of comparative neurology.

[33]  J. Sharp,et al.  DNQX inhibits phencyclidine (PCP) and ketamine induction of the hsp70 heat shock gene in the rat cingulate and retrosplenial cortex , 1995, Brain Research.

[34]  F. Sharp,et al.  Cerebellar toxicity of phencyclidine , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[35]  R. Duvoisin,et al.  The metabotropic glutamate receptors: Structure and functions , 1995, Neuropharmacology.

[36]  F. Sharp,et al.  Phencyclidine induction of the hsp70 stress gene in injured pyramidal neurons is mediated via multiple receptors and voltage gated calcium channels , 1994, Neuroscience.

[37]  J. Olney,et al.  Efficacy of clozapine compared with other antipsychotics in preventing NMDA-antagonist neurotoxicity. , 1994, The Journal of clinical psychiatry.

[38]  J. Krystal,et al.  Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. , 1994, Archives of general psychiatry.

[39]  J. Olney,et al.  Antipsychotic drugs block phencyclidine receptor-mediated neurotoxicity , 1993, Biological Psychiatry.

[40]  L. Noble,et al.  Haloperidol prevents induction of the hsp70 heat shock gene in neurons injured by phencyclidine (PCP), MK801, and ketamine , 1992, Journal of neuroscience research.

[41]  S. Nakanishi.  Molecular diversity of glutamate receptors and implications for brain function. , 1992, Science.

[42]  J. Olney,et al.  NMDA antagonist neurotoxicity: mechanism and prevention. , 1991, Science.

[43]  L. Noble,et al.  MK‐801 and ketamine induce heat shock protein HSP72 in injured neurons in posterior cingulate and retrosplenial cortex , 1991, Annals of neurology.

[44]  D. Javitt,et al.  Recent advances in the phencyclidine model of schizophrenia. , 1991, The American journal of psychiatry.

[45]  J. Olney,et al.  Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. , 1989, Science.

[46]  R. L. Reep,et al.  Rat posterior parietal cortex: topography of corticocortical and thalamic connections , 2004, Experimental Brain Research.

[47]  R. Auer,et al.  The nature and time course of neuronal vacuolation induced by the N-methyl-D-aspartate antagonist MK-801 , 2004, Acta Neuropathologica.

[48]  K. Dikranian,et al.  Receptor mechanisms and circuitry underlying NMDA antagonist neurotoxicity , 2002, Molecular Psychiatry.

[49]  G. Aghajanian,et al.  Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex. , 2000, The Journal of pharmacology and experimental therapeutics.

[50]  J. Olney,et al.  Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. , 1999, Science.

[51]  A. Belger,et al.  NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders. , 1999, Harvard review of psychiatry.

[52]  D. Schoepp,et al.  Tolerance to the motor impairment, but not to the reversal of PCP-induced motor activities by oral administration of the mGlu2/3 receptor agonist, LY379268 , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

[53]  J. Olney,et al.  Serotonergic Agents That Activate 5HT2A Receptors Prevent NMDA Antagonist Neurotoxicity , 1998, Neuropsychopharmacology.